Thyroid C-cells have the capacity to produce a variety of peptides, as do C-cell tumors. The cellular content of one such peptide, somatostatin, is restricted to a minority of C-cells in rat and human. We set out to clarify whether the synthesis of somatostatin is equally restricted and to study changes that occur in somatostatin synthesis with age. We used immunocytochemistry to localize somatostatin and calcitonin in conjunction with in situ hybridization, using digoxigeninlabeled oligoprobes to localize somatostatin and calcitonon "As in serial sections of formalin-fued, @membedded rat thyroid, and correlated peptide and mRNA content in individual cells. All C-cells synthesize and store uch 9, 1994; accepted March 17, 19% (3A3166).
Introduction
The C-cells ofthe rodent and human thyroid, characterized by their parafollicular position and their calcitonin content, produce a number of peptides, some of which modulate thyroid hormone secretion from follicular cells (1-3). The proportion of C-cells that contain detectable peptides other than calcitonin has been shown to alter with age. In particular, proportionately fewer C-cells contain immunocytochemically demonstrable somatostatin (43) or gastrinreleasing peptide (GRP) (6) demonstrable by immunocytochemistry (ICC) in adult animals compared with newborn animals. However, cells may synthesize some peptides, e.g., a growth factor, without necessarily storing them (7). It is not presently known whether C-cells containing peptides other than calcitonin in the adult are the only cells capable of synthesizing those peptides, or whether a wider group or even all C-cells synthesize somatostatin but only a minority retain sufficient hormone to be demonstrable by ICC.
The presence of mRNA for somatostatin and calcitonin can be demonstrated in tissue sections by in situ hybridization (ISH). This has frequently involved the use of radiolabeled probes on frozen sections (8-lo), but more recently both calcitonin in paraffin sections (11) (12) (13) and somatostatin in frozen sections (14) cell localization and facilitate correlation of peptide and mRNA content of individual cells in the same or serial sections. The presence of a species of mRNA within a cell makes it likely that synthesis of the appropriate peptide is taking place, although it is not absolute proof. The absence of a species of mRNA within a cell is not compatible with synthesis of the peptide concemed.
In this study we localized calcitonin and somatostatin peptides in rodent thyroid with immunocytochemistry and their respective "As with digoxigenin-labeled probes in formalin-fixed, paraffin-embedded material. To address the question of whether immunopositivity represents residual cell storage capacity rather than the retention of synthetic ability, we correlated the number of cells containing calcitonin and somatostatin peptide with their respective "As in serial sections of rat thyroid in juvenile (4-weekold) and mature (42-week-old) animals.
Materials and Methods
Wistar rats were maintained on Pillsbury's rat and mouse breeding diet and given drinking water ad libitum. Ten 4-week-old (five male and five female) and 10 42-week-old rats (five male and five female) were sacrificed by lethal injection of sodium pentobarbital. All animals were sacrificed at the same time of day. The thyroids were immediately removed and fmed in 10% neutral buffered formalin for 48 hr before routine processing and embedding in paraffin. Pancreas was obtained from 4-week-old animals only and was processed in the same manner as the thyroids.
Four-pm sections were taken from thepancreas and the central portion of each thyroid. Serial sections were used for immunocytochemistry and in situ hybridization. Immunocytochemistry. Somatostatin and calcitonin were localized in tissue sections by the indirect peroxidase method using polyclonal rabbit anti-human primary antibodies (Europath, Bude, Devon, UK) with swine anti-rabbit peroxidase-conjugated immunoglobulin as secondary antibody and DAB as the reporter molecule. Dilution profiles were performed for each antibody. The optimal dilution for calcitonin was 1:50 and for somato-5' end with a single molecule of digoxigenin. We have previously shown that both rat (12) and mouse (Thomas et al., submitted for publication) calcitonin mRNA can be localized using this calcitonin probe cocktail without further modification. A dilution profile was carried out for each probe to determine the optimal concentration. Modification ofthe somatostatin probe by additional digoxigenin labeling at the 3' end using the standard terminal transferase-catalyzed tailing procedure allowed further dilution of the probe by at least fivefold, leading to an increase in signal intensity and maintenance of low background (Figure 1) .
The protocol used for ISH has been described in detail elsewhere (12) . Briefly, sections were pre-treated in proteinase K (3 pglml for.30 min at 37°C) before pre-hybridization in buffer. Sections were then hybridized at 42°C overnight in 45 pl of hybridization buffer containing either 0.6 nglpl (total probe concentration) calcitonin probe, 1 nglpl >'-labeled or either 0.2 or 0.1 nglp15'. 3'-labeled somatostatin probe. After post-hybridization washes, bound probe was localized with alkaline phosphatase-linked anti-digoxigenin antibody (1:SOO) and enzyme histochemistry for alkaline phosphatase. Control sections were either pre-treated with RNAse (100 pglml) before hybridization with labeled probes, hybridized with an inappropriate probe (EBER 1 mRNA) (IS), or hybridized in the absence of labeled probe.
Correlation of Cell Peptide and mRNA Content. Eight serial transverse sections from the median area of one lobe of each,thyroid were analyzed with a computerized image analysis system and the total number of individual cells on each section positive for either mRNA (by ISH) or peptide (by ICC) was counted. Only cells with clearly visible nuclei were scored. Graphs were plotted and correlations calculated with a Cricket Graph software package.
Results

Immunocytochemistry
Calcitonin was present in all cells with the morphology of C-cells in the thyroids of both juvenile and mature rats (Figure 2) , and there was an obvious increase in the number of C-cells observed in the mature animals (Figure 4) .
Somatostatin was localized to the D-cells in the rat pancreas, confirming the specificity of the antibody (Figure 1 ). In rat thyroid, somatostatin was localized to cells with the morphology of C-cells (Figure 2) ; however, it was present only in a percentage of such cells. Cells positive for somatostatin were also positive for calcitonin in every case where the same cell could be identified in serial sections. The majority of calcitonin-positive cells did not contain somatostatin on serial sections. The somatostatin-positive cells in juvenile animals were present as isolated cells confined to a small part of the C-cell area. The numbers of somatostatin-positive cells increased with age, as did the number of calcitonin-positive cells. Somatostatin-positive cells remain confined to a small part of the C-cell area but often ringed entire follicles in the mature animals. i The percentage of somatostatin-positive C-cells did not significantly alter with age: 7.6% (range 6-9.5Y0) in young animals compared with 10.6% (range 8-17%) in mature animals. statin 1:lOO. Controls included omission of primary antibody and use of an irrelevant antibody.
In Situ Hybridization. A cocktail of three 28-29-base D N A oligoprobes to human calcitonin =On 4 and a single 42-base c~~~ oligoprobe to rat somatostatin 14 (British Biotechnology Products; Abingdon, Oxford, UK) were used. All probes were anti-sense in sequence and were labeled at the
In Situ Hybridization
Calcitonin mRNA was clearly restricted to cells with the morphology of C-cells in rat thyroid, and showed little heterogeneity with respect to staining (Figure 2) . Serial section studies showed that in individual animals the number of cells positive for calcitonin peptide correlated well (7 = 0.893) with the number and localization of positive cells on the serial section hybridized with calcitonin probe ( Figure 3A ). There was an age-associated increase in C-cells positive for calcitonin mRNA, which was consistent with the age-associated increase in immunopositive cells (Figure 4) . Somatostatin mRNA was localized in rat pancreas only to the D-cells ( Figure 1 ) and in the rat thyroid to a proportion of C-cells ( Figure  2 ). Peptide positivity correlated well with mRNA positivity (7 = 0.986) ( Figure 3B ). All cells positive for somatostatin mRNA and present on serial sections were also positive for somatostatin and calcitonin peptide and "A.
In the juvenile animals, isolated somatostatin-positive cells were found; aggregates of cells were more common in the mature animals (Figure 2) . confirming the distribution of the peptide-positive cells.
The variation among individual animals in the numbers of somatostatin &Aand of calcitonin "A-positive cells probably results from the non-random distribution of C-cells in the thyroid. C-cells are usually more common in the center than in the periphery of each lobe of the rodent thyroid, but the area with the highest concentration of C-cells is not consistently located. Although care was taken to use sections only from the center of the thyroid lobe, an accurate count of C-cells in a thyroid would require counting the cells in at least subserial sections through the gland. Nevertheless, in the sections studied there was a significant increase in the number of C-cells positive for calcitonin mRNA and in the number positive for somatostatin mRNA in mature compared with juvenile animals (Figure 4) .
We have developed a technique using a single digoxigenin-labeled oligoprobe to localize somatostatin in formalin-fixed, paraffinembedded rat pancreas and thyroid. We have correlated peptide content, demonstrated by ICC, and " A content, demonstrated by ISH, of both somatostatin and calcitonin in C-cells of the rat thyroid of juvenile (4-week-old) and mature (42-week-old) animals.
We have shown that peptide and mRNA content of both of these factors correlates well in individual cells on serial sections, providing evidence for the continued coordinated storage and synthesis of both of these hormones in the rodent thyroid. Age-related changes have previously been reported for both peptide and mRNA content of C-cells when comparisons were made between neonates and adults. In the 6-day-old rat, 90% of C-cells were immunopositive for somatostatin, whereas in the adult only 1% of cells were positive. (5). The diminution in the proportion of C-cells containing somatostatin in rat thyroid could be the result of a selective overgrowth of C-cells negative for somatostatin. This seems unlikely, as there is a particularly large decrease (m50%) in the number of somatostatin cells positive on ICC between Days 6 and 8 after birth of the rat. On the basis of ICC data alone, it is possible that the reduction of somatostatin-positive cells results from a decrease in storage capacity by some cells, rather than a decrease in synthetic capacity.
Our study has shown that in the juvenile rat there is no excess of somatostatin-synthesizing cells, as judged by mRNA content, over somatostatin-immunopositive cells, making this explanation unlikely. We go on to show that the number of somatostatin peptideand "A-containing C-cells increases considerably in adult lifc in the rat, in parallel with the increase in calcitonin-positive cells, as has been previously shown by ICC (5~6.17). This increase is confined to one area of the C-cell-bearing part of the gland. These observations suggest that production of somatostatin is not a facultative property of many C-cells but that during neonatal life C-cells differentiate into two types, one producing calcitonin but not somatostatin and the other producing both hormones. The description of the production of an autonomous somatostatin-producing cell line from a mouse medullary carcinoma supports this (18) .
The functional role of somatostatin production by a subset of C-cells is not known. Because both production and storage are limited to a small area of the thyroid lobe, it is diffiult to envisage a general role in the control of thyroid hormone synthesis, even though somatostatin is known to show direct effects on follicular cells (3). The C-cells produce a variety of peptide hormones, and the proportion of cells producing gastrin-releasing peptide (GRP) has been shown to fall with age in human thyroid (6). C-cells are known to show cell processes that ramlfy around the base of the follicular cells, and it is likely that they release hormone locally. The physiological role, if any, of locally produced somatostatin, GRP, and a number of other peptides remains to be elucidated, as do the mechanisms that control their production in medullary carcinoma.
The combination of ISH and ICC provides valuable information; we have used it here to study age-related changes in peptide hormone synthesis, but it is obviously applicable to a number of problems in tumor diagnosis. Peptide storage is frequently diminished in tumors, making identification of the cell of origin mi-
